Neuronetics (STIM) Debt to Equity (2017 - 2025)
Neuronetics (STIM) has disclosed Debt to Equity for 9 consecutive years, with $2.44 as the latest value for Q3 2025.
- On a quarterly basis, Debt to Equity fell 50.3% to $2.44 in Q3 2025 year-over-year; TTM through Sep 2025 was $2.44, a 50.3% decrease, with the full-year FY2024 number at $2.03, up 16.88% from a year prior.
- Debt to Equity was $2.44 for Q3 2025 at Neuronetics, up from $1.79 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $4.9 in Q3 2024 to a low of $0.34 in Q1 2021.
- A 5-year average of $1.36 and a median of $0.81 in 2023 define the central range for Debt to Equity.
- Peak YoY movement for Debt to Equity: crashed 69.45% in 2021, then skyrocketed 404.88% in 2024.
- Neuronetics' Debt to Equity stood at $0.41 in 2021, then skyrocketed by 51.89% to $0.63 in 2022, then skyrocketed by 175.18% to $1.73 in 2023, then rose by 16.88% to $2.03 in 2024, then increased by 20.25% to $2.44 in 2025.
- Per Business Quant, the three most recent readings for STIM's Debt to Equity are $2.44 (Q3 2025), $1.79 (Q2 2025), and $1.43 (Q1 2025).